Mather Group LLC. Purchases 21 Shares of McKesson Co. (NYSE:MCK)

Mather Group LLC. lifted its position in McKesson Co. (NYSE:MCK) by 2.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 862 shares of the company’s stock after acquiring an additional 21 shares during the quarter. Mather Group LLC.’s holdings in McKesson were worth $491,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in MCK. Wolff Wiese Magana LLC raised its holdings in shares of McKesson by 742.9% in the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after acquiring an additional 52 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in McKesson in the third quarter valued at about $29,000. RPg Family Wealth Advisory LLC purchased a new position in McKesson in the third quarter valued at about $31,000. Synergy Asset Management LLC purchased a new position in McKesson in the fourth quarter valued at about $32,000. Finally, Crews Bank & Trust purchased a new position in McKesson in the fourth quarter valued at about $33,000. 85.07% of the stock is currently owned by institutional investors.

McKesson Trading Up 0.3 %

Shares of NYSE:MCK opened at $605.37 on Thursday. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51. The company has a market capitalization of $76.85 billion, a PE ratio of 31.35, a PEG ratio of 1.29 and a beta of 0.52. The business has a 50 day moving average of $590.03 and a two-hundred day moving average of $562.26.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. Equities research analysts predict that McKesson Co. will post 32.72 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be issued a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date is Monday, March 3rd. McKesson’s payout ratio is presently 14.71%.

Analyst Ratings Changes

MCK has been the topic of several analyst reports. Evercore ISI lifted their target price on McKesson from $560.00 to $680.00 and gave the company an “outperform” rating in a research note on Thursday, November 7th. StockNews.com upgraded McKesson from a “hold” rating to a “buy” rating in a research note on Wednesday, November 6th. Wells Fargo & Company boosted their price target on McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a research note on Friday, December 13th. Morgan Stanley boosted their price target on McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Finally, Mizuho started coverage on McKesson in a research note on Wednesday, December 4th. They set a “neutral” rating and a $630.00 price target on the stock. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $646.14.

Insider Buying and Selling at McKesson

In other news, EVP Leann B. Smith sold 579 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $602.81, for a total transaction of $349,026.99. Following the completion of the transaction, the executive vice president now directly owns 1,443 shares of the company’s stock, valued at $869,854.83. This represents a 28.64 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 0.11% of the stock is currently owned by corporate insiders.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.